Bone Metastases: Molecular Mechanisms and Novel Therapeutic Interventions
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bone Metastases: Molecular Mechanisms and Novel Therapeutic Interventions
Authors
Keywords
-
Journal
MEDICINAL RESEARCH REVIEWS
Volume 32, Issue 3, Pages 611-636
Publisher
Wiley
Online
2010-09-05
DOI
10.1002/med.20224
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prostate Cancer Cell-Derived Urokinase-Type Plasminogen Activator Contributes to Intraosseous Tumor Growth and Bone Turnover
- (2015) Zhong Dong et al. NEOPLASIA
- MicroRNAs: Crucial multi-tasking components in the complex circuitry of tumor metastasis
- (2011) Scott Valastyan et al. CELL CYCLE
- microRNA, Cell Cycle, and Human Breast Cancer
- (2010) Zuoren Yu et al. AMERICAN JOURNAL OF PATHOLOGY
- Role of HIF-1α in skeletal development
- (2010) Chao Wan et al. Annals of the New York Academy of Sciences
- Results of a prospective, randomized, double-blind, double-dummy, Phase 3 study comparing denosumab with zoledronic acid for the treatment of breast cancer patients with bone metastases
- (2010) Jean-Jacques Body et al. BONE
- Pulse treatment with zoledronic acid causes sustained commitment of bone marrow derived mesenchymal stem cells for osteogenic differentiation
- (2009) Regina Ebert et al. BONE
- Cancer stem cells in breast cancer and metastasis
- (2009) Jessica C. Lawson et al. BREAST CANCER RESEARCH AND TREATMENT
- Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival Signals
- (2009) Xiang H.-F. Zhang et al. CANCER CELL
- WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics
- (2009) Isabelle Bisson et al. CELL RESEARCH
- Effect of the Cathepsin K Inhibitor Odanacatib on Bone Resorption Biomarkers in Healthy Postmenopausal Women: Two Double-Blind, Randomized, Placebo-Controlled Phase I Studies
- (2009) S A Stoch et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Future therapeutic targets in osteoporosis
- (2009) Chad Deal CURRENT OPINION IN RHEUMATOLOGY
- Emerging therapeutic targets in breast cancer bone metastasis
- (2009) April AN Rose et al. Future Oncology
- Effects of denosumab in patients with bone metastases with and without previous bisphosphonate exposure
- (2009) Jean-Jacques Body et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
- (2009) Matthew R. Smith et al. JOURNAL OF UROLOGY
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
- (2009) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Role of Src in Solid Tumors
- (2009) D. L. Wheeler et al. ONCOLOGIST
- Hypoxia and TGF-β Drive Breast Cancer Bone Metastases through Parallel Signaling Pathways in Tumor Cells and the Bone Microenvironment
- (2009) Lauren K. Dunn et al. PLoS One
- A Physical Mechanism for Coupling Bone Resorption and Formation in Adult Human Bone
- (2008) Thomas Levin Andersen et al. AMERICAN JOURNAL OF PATHOLOGY
- Targeting Src in breast cancer
- (2008) R. S. Finn ANNALS OF ONCOLOGY
- Regulation of bone remodeling by the central and peripheral nervous system
- (2008) Florent Elefteriou ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Functions of RANKL/RANK/OPG in bone modeling and remodeling
- (2008) Brendan F. Boyce et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Bone density, strength, and formation in adult cathepsin K (−/−) mice
- (2008) B. Pennypacker et al. BONE
- Osteonecrosis of the jaw — Who gets it, and why?
- (2008) Ian R. Reid BONE
- Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone-refractory prostate cancer
- (2008) Joel B. Nelson et al. CANCER
- Osteotropic cancers: From primary tumor to bone
- (2008) Jeroen T. Buijs et al. CANCER LETTERS
- Evolving role of uPA/uPAR system in human cancers
- (2008) Kathleen Dass et al. CANCER TREATMENT REVIEWS
- T Cells Potentiate PTH-Induced Cortical Bone Loss through CD40L Signaling
- (2008) Yuhao Gao et al. Cell Metabolism
- Safety and Efficacy of the Specific Endothelin-A Receptor Antagonist ZD4054 in Patients with Hormone-Resistant Prostate Cancer and Bone Metastases Who Were Pain Free or Mildly Symptomatic: A Double-Blind, Placebo-Controlled, Randomised, Phase 2 Trial
- (2008) Nicholas D. James et al. EUROPEAN UROLOGY
- The endothelin axis in cancer
- (2008) Anna Bagnato et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis*
- (2008) Xiaodong Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Endothelial cells and normal breast epithelial cells enhance invasion of breast carcinoma cells by CXCR-4-dependent up-regulation of urokinase-type plasminogen activator receptor (uPAR, CD87) expression
- (2008) S Serratì et al. JOURNAL OF PATHOLOGY
- Antitumor Effects of Doxorubicin Followed by Zoledronic Acid in a Mouse Model of Breast Cancer
- (2008) P. D. Ottewell et al. JNCI-Journal of the National Cancer Institute
- A soluble activin Type IIA receptor induces bone formation and improves skeletal integrity
- (2008) R. S. Pearsall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bone remodeling: Multiple cellular interactions required for coupling of bone formation and resorption
- (2008) Natalie A. Sims et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now